Question:
Schedule ‘O’ governs the standards for:
Schedule ‘O’ governs the standards for:
Updated On: Jul 20, 2024
- List of equipment to run a pharmacy
- Life period (expiry) of drugs
- Dininfectant fluids
- Manufacturing and analytical records of drugs
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C): Dininfectant fluids
Was this answer helpful?
0
0
Top Questions on Disorders of fluid, electrolyte and acid-base balance
- A 10-year-old child weighing 30 kg presents with a history of loose stools for 2 days. On examination, there is severe dehydration. Laboratory investigations are as follows. What is the initial management as per ISPAD guidelines?
RBS 550mg/dL pH 7.01 Na+ 158mEq/L Urine glucose 3+
- NEET (PG) - 2023
- Pediatrics
- Disorders of fluid, electrolyte and acid-base balance
- Which one of the following electrolytes has the same value of van't Hoff factor \((i)\) as that of \(K_4[Fe(CN)_6]\) ?
- JIPMER MBBS - 2018
- Chemistry
- Disorders of fluid, electrolyte and acid-base balance
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions